Hematology Highlights: A Post ASH Review
UNMC 2020 Lymphoma Study Group & Hematology Highlights: A Post ASH Review
Rivaroxaban Inferior to Warfarin in Prevention of Recurrent Thrombosis in Antiphospholipid Ab Syndrome & Andexanet and Idarucizumab Safe and Effective at Reversing Anticoagulant Effects of DOACs
FEATURING
Brandon J. McMahon
- 213 views
- March 9, 2020
- 1
UNMC 2020 Lymphoma Study Group & Hematology Highlights: A Post ASH Review
ASH 2019 Myeloma Highlights: Genetic Engineering of T-cells, Dara-VMP for Transplant-ineligible Pts, D-RVd as a Potential SOC for Transplant-eligible Pts & Prognostic Value of PET-CT
FEATURING
Ashley Rosko
- 21 views
- March 9, 2020